{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:31:40Z","timestamp":1794562300241,"version":"4.9.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14583-1","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:12:39Z","timestamp":1753891959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Cerebrospinal fluid Circulating Tumor DNA (ctDNA) as a biomarker for CNS metastases in Non-Small Cell Lung Cancer (NSCLC): a systematic review and meta-analysis comparing CSF ctDNA and traditional methods"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6819-8015","authenticated-orcid":false,"given":"Oluwatobi O.","family":"Olayode","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blessing T.","family":"Ogunoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel Olusola","family":"Oladeji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwafemi E.","family":"Olayinka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tolulope J.","family":"Oladosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"issue":"3","key":"14583_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"18","key":"14583_CR2","doi-asserted-by":"publisher","first-page":"4705","DOI":"10.3390\/cancers13184705","volume":"13","author":"O Rodak","year":"2021","unstructured":"Rodak O, Peris-D\u00edaz MD, Olbromski M, Podhorska-Oko\u0142\u00f3w M, Dzi\u0119giel P. Current landscape of non-small cell lung cancer: epidemiology, histological classification, targeted therapies, and immunotherapy. Cancers. 2021;13(18):4705.","journal-title":"Cancers"},{"issue":"1","key":"14583_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3171\/2010.8.GKS10994","volume":"113","author":"WS Chang","year":"2010","unstructured":"Chang WS, Kim HY, Chang JW, Park YG, Chang JH. Analysis of radiosurgical results in patients with brain metastases according to the number of brain lesions: is stereotactic radiosurgery effective for multiple brain metastases?: Clinical article. J Neurosurg. 2010;113(1):73\u20138.","journal-title":"J Neurosurg."},{"issue":"10","key":"14583_CR4","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1200\/JCO.2016.69.7144","volume":"35","author":"WJ Magnuson","year":"2017","unstructured":"Magnuson WJ, Lester-Coll NH, Wu AJ, Yang TJ, Lockney NA, Gerber NK, et al. Management of brain metastases in tyrosine kinase inhibitor-na\u00efve epidermal growth factor receptor-mutant non\u2013small-cell lung cancer: a retrospective multi-institutional analysis. J Clin Oncol. 2017;35(10):1070\u20137.","journal-title":"J Clin Oncol"},{"issue":"4","key":"14583_CR5","doi-asserted-by":"publisher","first-page":"e373","DOI":"10.1016\/j.cllc.2018.01.007","volume":"19","author":"SN Waqar","year":"2018","unstructured":"Waqar SN, Samson PP, Robinson CG, Bradley J, Devarakonda S, Du L, et al. Non\u2013small-cell lung cancer with brain metastasis at presentation. Clin Lung Cancer. 2018;19(4):e373\u20139.","journal-title":"Clin Lung Cancer"},{"issue":"3","key":"14583_CR6","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1148\/radiol.2423051707","volume":"242","author":"A Mujoomdar","year":"2007","unstructured":"Mujoomdar A, Austin JHM, Malhotra R, Powell CA, Pearson GDN, Shiau MC, et al. Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: primary tumor size, cell type, and lymph node metastases. Radiology. 2007;242(3):882\u20138.","journal-title":"Radiology"},{"issue":"1","key":"14583_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/nop\/npae075","volume":"12","author":"B Aygun","year":"2025","unstructured":"Aygun B, Biswas A, Blaaza M, Cooper J, Gaur P, Avsenik J, et al. Improved diagnostic accuracy for leptomeningeal dissemination in pediatric brain tumors using contrast-enhanced FLAIR imaging. Neuro-Oncol Pract. 2025;12(1):51\u20137.","journal-title":"Neuro-Oncol Pract"},{"key":"14583_CR8","doi-asserted-by":"crossref","unstructured":"Harris P, Diouf A, Guilbert F, Ameur F, Letourneau-Guillon L, M\u00e9nard C, et al. Diagnostic reliability of leptomeningeal disease using magnetic resonance imaging. Cureus. 2019. Available from: https:\/\/www.cureus.com\/articles\/14746-diagnostic-reliability-of-leptomeningeal-disease-using-magnetic-resonance-imaging. Cited 2025 Mar 12.","DOI":"10.7759\/cureus.4416"},{"issue":"1","key":"14583_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3390\/diagnostics12010079","volume":"12","author":"F Otto","year":"2021","unstructured":"Otto F, Harrer C, Pilz G, Wipfler P, Harrer A. Role and relevance of cerebrospinal fluid cells in diagnostics and research: state-of-the-art and underutilized opportunities. Diagnostics. 2021;12(1):79.","journal-title":"Diagnostics"},{"issue":"30","key":"14583_CR10","doi-asserted-by":"publisher","first-page":"48832","DOI":"10.18632\/oncotarget.9453","volume":"7","author":"F Cheng","year":"2016","unstructured":"Cheng F, Su L, Qian C. Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer. Oncotarget. 2016;7(30):48832\u201341.","journal-title":"Oncotarget"},{"issue":"1","key":"14583_CR11","doi-asserted-by":"publisher","first-page":"8839","DOI":"10.1038\/ncomms9839","volume":"6","author":"L De Mattos-Arruda","year":"2015","unstructured":"De Mattos-Arruda L, Mayor R, Ng CK, Weigelt B, Mart\u00ednez-Ricarte F, Torrejon D, et al. Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma. Nat Commun. 2015;6(1):8839.","journal-title":"Nat Commun"},{"issue":"3","key":"14583_CR12","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/1759-7714.13300","volume":"11","author":"C Ma","year":"2020","unstructured":"Ma C, Yang X, Xing W, Yu H, Si T, Guo Z. Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples. Thorac Cancer. 2020;11(3):588\u201393.","journal-title":"Thorac Cancer"},{"issue":"12","key":"14583_CR13","first-page":"1363","volume":"20","author":"AM Miller","year":"2022","unstructured":"Miller AM, Karajannis MA. Current role and future potential of CSF ctDNA for the diagnosis and clinical management of pediatric central nervous system tumors. J Natl Compr Cancer Netw JNCCN. 2022;20(12):1363\u20139.","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"issue":"1","key":"14583_CR14","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41392-024-02021-w","volume":"9","author":"L Ma","year":"2024","unstructured":"Ma L, Guo H, Zhao Y, Liu Z, Wang C, Bu J, et al. Liquid biopsy in cancer: current status, challenges and future prospects. Signal Transduct Target Ther. 2024;9(1):336.","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"14583_CR15","doi-asserted-by":"publisher","first-page":"e154941","DOI":"10.1172\/JCI154941","volume":"132","author":"DK Dang","year":"2022","unstructured":"Dang DK, Park BH. Circulating tumor DNA: current challenges for clinical utility. J Clin Invest. 2022;132(12):e154941.","journal-title":"J Clin Invest"},{"issue":"8","key":"14583_CR16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AWS, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529\u201336.","journal-title":"Ann Intern Med"},{"issue":"7","key":"14583_CR17","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. PLoS Med. 2009;6(7):e1000097.","journal-title":"PLoS Med."},{"issue":"14","key":"14583_CR18","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1111\/1759-7714.14866","volume":"14","author":"CL Chiang","year":"2023","unstructured":"Chiang CL, Ho HL, Yeh YC, Lee CC, Huang HC, Shen CI, et al. Efficacy of different platforms in detecting EGFR mutations using cerebrospinal fluid cell-free DNA from non-small-cell lung cancer patients with leptomeningeal metastases. Thorac Cancer. 2023;14(14):1251\u20139.","journal-title":"Thorac Cancer"},{"key":"14583_CR19","doi-asserted-by":"crossref","unstructured":"Geng D, Niu R, Li J, Guo S, Guo Q, Huang S, et al. EGFR amplification indicated poor prognosis in EGFR-mutated lung cancer with leptomeningeal metastases. Clin Respir J. 2024;18(2). Available from: https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L2028193482&from=export.","DOI":"10.1111\/crj.13733"},{"key":"14583_CR20","unstructured":"Shen F, Liang N, Fan Z, Zhao M, Kang J, Wang X, et al. Genomic Alterations Identification and Resistance Mechanisms Exploration of NSCLC With Central Nervous System Metastases Using Liquid Biopsy of Cerebrospinal Fluid: A Real-World Study. Front Oncol. 2022;12((Shen F.; Guo W., guowei812@126.com) Department of Respiratory Medicine, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital, Affiliated to Shanxi Medical University, Taiyuan, China). Available from: https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L2018159712&from=export."},{"key":"14583_CR21","doi-asserted-by":"crossref","unstructured":"Yang H, Wen L, Zhao C, Chen J, Zhou Z, Zhou C, et al. Cerebrospinal fluid-derived circulating tumor DNA is more comprehensive than plasma in NSCLC patients with leptomeningeal metastases regardless of extracranial evolution. Heliyon. 2022;8(12). Available from: https:\/\/www.cell.com\/heliyon\/fulltext\/S2405-8440(22)03662-3. Cited 2025 Feb 20.","DOI":"10.1016\/j.heliyon.2022.e12374"},{"key":"14583_CR22","unstructured":"Zhang L, Wu J, Liu Z, Huang T, Wang Y, Song M, et al. Cerebrospinal fluid circulating tumor DNA depicts profiling of brain metastasis in NSCLC. 2022. Available from: https:\/\/scholar.archive.org\/work\/3qradizdurcdpcarorqcsq357q\/access\/wayback\/https:\/\/assets.researchsquare.com\/files\/rs-1509960\/v1\/a77c81cd-de09-4554-8649-f362087ab21b.pdf?c=1652679045. Cited 2025 Feb 20."},{"issue":"19","key":"14583_CR23","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1111\/1759-7714.14936","volume":"14","author":"L Shi","year":"2023","unstructured":"Shi L, Guo L, Tao H, Meng Q, Tong L, Tang J, et al. Genetic profiling of circulating cell-free DNA from cerebrospinal fluid and paired plasma in ALK-positive lung cancer with brain metastases. Thorac Cancer. 2023;14(19):1883\u201393.","journal-title":"Thorac Cancer"},{"key":"14583_CR24","doi-asserted-by":"crossref","unstructured":"Shi L, Tang J, Tao H, Guo L, Wu W, Wu H, et al. Detection of EGFR Mutations in Cerebrospinal Fluid of EGFR-Mutant Lung Adenocarcinoma With Brain Metastases. Front Oncol. 2021;11((Shi L.; Tang J.; Tao H.; Guo L.; Wu W.; Wu H.; Tong L.; Wu W.; Li H.; Meng Q.; Xu L.; Liu Z.) Department of Medical Oncology, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China). Available from: https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L634653950&from=export.","DOI":"10.3389\/fonc.2021.622142"},{"issue":"1","key":"14583_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100305","volume":"7","author":"M Li","year":"2022","unstructured":"Li M, Hou X, Zheng L, Ma Y, Li D, Lv Y, et al. Utilizing phenotypic characteristics of metastatic brain tumors to improve the probability of detecting circulating tumor DNA from cerebrospinal fluid in non-small-cell lung cancer patients: development and validation of a prediction model in a prospective cohort study. ESMO Open. 2022;7(1): 100305.","journal-title":"ESMO Open"},{"issue":"1","key":"14583_CR26","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1186\/s12916-022-02595-8","volume":"20","author":"M Li","year":"2022","unstructured":"Li M, Chen J, Zhang B, Yu J, Wang N, Li D, et al. Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases: a prospective cohort study (GASTO 1028). BMC Med. 2022;20(1):398.","journal-title":"BMC Med"},{"issue":"3","key":"14583_CR27","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jtho.2019.11.024","volume":"15","author":"M Aldea","year":"2020","unstructured":"Aldea M, Hendriks L, Mezquita L, Jovelet C, Planchard D, Auclin E, et al. Circulating tumor DNA analysis for patients with oncogene-addicted NSCLC with isolated central nervous system progression. J Thorac Oncol. 2020;15(3):383\u201391.","journal-title":"J Thorac Oncol"},{"issue":"18","key":"14583_CR28","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1111\/1759-7714.14592","volume":"13","author":"N Nie","year":"2022","unstructured":"Nie N, Zhou H, Zhang K, Liu L, Luo N, Wang R, et al. Genotyping of cerebrospinal fluid in lung cancer patients with leptomeningeal metastasis. Thorac Cancer. 2022;13(18):2574\u201383.","journal-title":"Thorac Cancer."},{"issue":"8","key":"14583_CR29","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1111\/1759-7714.13123","volume":"10","author":"N Li","year":"2019","unstructured":"Li N, Liu Y, Duan J, Yang B, Bai H, Sun R, et al. Prognostic significance of molecular characteristics of cerebrospinal fluid for non-small cell lung cancer patients with leptomeningeal metastasis. Thorac Cancer. 2019;10(8):1673\u201382.","journal-title":"Thorac Cancer"},{"issue":"1","key":"14583_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s40478-024-01846-4","volume":"12","author":"RA Hickman","year":"2024","unstructured":"Hickman RA, Miller AM, Holle BM, Jee J, Liu SY, Ross D, et al. Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumors. Acta Neuropathol Commun. 2024;12(1):151.","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"14583_CR31","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11523-019-00645-5","volume":"14","author":"R Huang","year":"2019","unstructured":"Huang R, Xu X, Li D, Chen K, Zhan Q, Ge M, et al. Digital PCR-based detection of EGFR mutations in paired plasma and CSF samples of lung adenocarcinoma patients with central nervous system metastases. Target Oncol. 2019;14(3):343\u201350.","journal-title":"Target Oncol"},{"issue":"2","key":"14583_CR32","first-page":"128","volume":"34","author":"R Huang","year":"2019","unstructured":"Huang R, Ge M, Zhou X, Ji X, Liao L, Liang X, et al. Epidermal growth factor receptor mutation detection in cerebrospinal fluid of lung adenocarcinoma patients with leptomeningeal metastasis. Cancer Biother Radiopharm. 2019;34(2):128\u201333.","journal-title":"Cancer Biother Radiopharm"},{"key":"14583_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2024.101113","volume":"60","author":"SK Liang","year":"2025","unstructured":"Liang SK, Liao WY, Shih JY, Hsu CL, Yang CY, Wu SG, et al. Clinical utility and predictive value of cerebrospinal fluid cell-free DNA profiling in non-small cell lung cancer patients with leptomeningeal metastasis. Neoplasia. 2025;60: 101113.","journal-title":"Neoplasia"},{"issue":"1","key":"14583_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41698-024-00582-1","volume":"8","author":"TD Azad","year":"2024","unstructured":"Azad TD, Nanjo S, Jin MC, Chabon JJ, Kurtz DM, Chaudhuri AA, et al. Quantification of cerebrospinal fluid tumor DNA in lung cancer patients with suspected leptomeningeal carcinomatosis. NPJ Precis Oncol. 2024;8(1):121.","journal-title":"NPJ Precis Oncol"},{"key":"14583_CR35","doi-asserted-by":"crossref","unstructured":"Di WY, Chen YN, Cai Y, Geng Q, Tan YL, Li CH, et al. The diagnostic significance of cerebrospinal fluid cytology and circulating tumor DNA in meningeal carcinomatosis. Front Neurol. 2023;14((Di W.-Y.; Cheng S.-J., chengshuj@126.com) Clinical Medical College, Hebei University, Baoding, China). Available from: https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L2022131959&from=export.","DOI":"10.3389\/fneur.2023.1076310"},{"issue":"1","key":"14583_CR36","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00432-020-03324-5","volume":"147","author":"W Choi","year":"2021","unstructured":"Choi W, Cho Y, Park SY, Hwang KH, Han JY, Lee Y. A nanowire-based liquid biopsy method using cerebrospinal fluid cell-free DNA for targeted management of leptomeningeal carcinomatosis. J Cancer Res Clin Oncol. 2021;147(1):213\u201322.","journal-title":"J Cancer Res Clin Oncol"},{"key":"14583_CR37","unstructured":"Wu X, Xing P, Shi M, Guo W, Zhao F, Zhu H, et al. Cerebrospinal Fluid Cell-Free DNA-Based Detection of High Level of Genomic Instability Is Associated With Poor Prognosis in NSCLC Patients With Leptomeningeal Metastases. Front Oncol. 2022;12((Wu X.) General Department, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China). Available from: https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L2016733478&from=export."},{"issue":"11","key":"14583_CR38","doi-asserted-by":"publisher","first-page":"S1771","DOI":"10.1016\/j.jtho.2017.09.383","volume":"12","author":"B Jiang","year":"2017","unstructured":"Jiang B, Li Y, Yang J, Yang X, Zhou Q, Zhong W, et al. Unique genetic profiles from circulating Cell-Free DNA of cerebrospinal fluid in leptomeningeal metastases of EGFR Mutant NSCLC. J Thorac Oncol. 2017;12(11):S1771.","journal-title":"J Thorac Oncol"},{"key":"14583_CR39","doi-asserted-by":"crossref","unstructured":"Xu Y, Hu M, Zhang M, Zhong W, Yin X, Sun Y, et al. Prospective study revealed prognostic significance of responses in leptomeningeal metastasis and clinical value of cerebrospinal fluid-based liquid biopsy. Lung Cancer. 2018;125((Xu Y., maraxu@163.com; Zhong W., weizhong3603@sina.com; Chen M., minjiangchen@163.com; Zhao J., pumchzj@sina.com; Si X., xiaoyanfff@sina.com; Wang H., wanghanping78@hotmail.com; Zhang X., zhangxtpumch@126.com; Zhang L., zhanglipumch@aliyun.com; Wang M., mengzhaowang@sina.com) Department of Respiratory Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Beijing, China):142\u20139.","DOI":"10.1016\/j.lungcan.2018.08.017"},{"issue":"2","key":"14583_CR40","doi-asserted-by":"publisher","first-page":"914","DOI":"10.21037\/tlcr-21-62","volume":"10","author":"Y Liu","year":"2021","unstructured":"Liu Y, Yang S, Zhao J, He Z, Ma J, Guo Y, et al. Cell-free DNA from cerebrospinal fluid can be used to detect the EGFR mutation status of lung adenocarcinoma patients with central nervous system metastasis. Transl Lung Cancer Res. 2021;10(2):914\u201325.","journal-title":"Transl Lung Cancer Res"},{"key":"14583_CR41","doi-asserted-by":"crossref","unstructured":"Wang Y, Jiang F, Xia R, Li M, Yao C, Li Y, et al. Unique Genomic Alterations of Cerebrospinal Fluid Cell-Free DNA Are Critical for Targeted Therapy of Non-Small Cell Lung Cancer With Leptomeningeal Metastasis. Front Oncol. 2021;11((Wang Y.; Li M.; Li Y.; Li H.; Zhao Q.; Shi M.; Yu Y.; Miao L.; Cai H.) Department of Respiratory Medicine Radiology Cardiothoracic Surgery, Nanjing Drum Tower Hospital Affiliated to Medical School, Nanjing University, Nanjing, China). Available from: https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L636223145&from=export.","DOI":"10.3389\/fonc.2021.701171"},{"key":"14583_CR42","doi-asserted-by":"crossref","unstructured":"Zhao Y, He JY, Zou YL, Guo XS, Cui JZ, Guo L, et al. Evaluating the cerebrospinal fluid ctDNA detection by next-generation sequencing in the diagnosis of meningeal Carcinomatosis. BMC Neurol. 2019;19(1). Available from: https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L630288121&from=export.","DOI":"10.1186\/s12883-019-1554-5"},{"key":"14583_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101720","volume":"34","author":"W Wang","year":"2023","unstructured":"Wang W, He Y, Yang F, Chen K. Current and emerging applications of liquid biopsy in pan-cancer. Transl Oncol. 2023;34: 101720.","journal-title":"Transl Oncol"},{"key":"14583_CR44","doi-asserted-by":"crossref","unstructured":"Adhit KK, Wanjari A, Menon S, K S. Liquid Biopsy: An Evolving Paradigm for Non-invasive Disease Diagnosis and Monitoring in Medicine. Cureus. 2023. Available from: https:\/\/www.cureus.com\/articles\/185600-liquid-biopsy-an-evolving-paradigm-for-non-invasive-disease-diagnosis-and-monitoring-in-medicine. Cited 2025 Mar 12.","DOI":"10.7759\/cureus.50176"},{"key":"14583_CR45","doi-asserted-by":"publisher","first-page":"153303382110437","DOI":"10.1177\/15330338211043784","volume":"20","author":"Y Lu","year":"2021","unstructured":"Lu Y, Li L. The prognostic value of circulating tumor DNA in ovarian cancer: a meta-analysis. Technol Cancer Res Treat. 2021;20:15330338211043784.","journal-title":"Technol Cancer Res Treat"},{"issue":"28","key":"14583_CR46","doi-asserted-by":"publisher","first-page":"44583","DOI":"10.18632\/oncotarget.10069","volume":"7","author":"B Ai","year":"2016","unstructured":"Ai B, Liu H, Huang Y, Peng P. Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer. Oncotarget. 2016;7(28):44583\u201395.","journal-title":"Oncotarget"},{"issue":"1","key":"14583_CR47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jtho.2016.08.002","volume":"12","author":"S Cargnin","year":"2017","unstructured":"Cargnin S, Canonico PL, Genazzani AA, Terrazzino S. Quantitative analysis of circulating cell-free DNA for correlation with lung cancer survival: a systematic review and meta-analysis. J Thorac Oncol. 2017;12(1):43\u201353.","journal-title":"J Thorac Oncol"},{"issue":"2","key":"14583_CR48","doi-asserted-by":"publisher","first-page":"e0171991","DOI":"10.1371\/journal.pone.0171991","volume":"12","author":"G Fan","year":"2017","unstructured":"Fan G, Zhang K, Yang X, Ding J, Wang Z, Li J. Prognostic value of circulating tumor DNA in patients with colon cancer: Systematic review. Chan KYK, editor. PLoS One. 2017;12(2):e0171991.","journal-title":"PLoS One."},{"issue":"1","key":"14583_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/2045-8118-8-14","volume":"8","author":"CL Weston","year":"2011","unstructured":"Weston CL, Glantz MJ, Connor JR. Detection of cancer cells in the cerebrospinal fluid: current methods and future directions. Fluids Barriers CNS. 2011;8(1): 14.","journal-title":"Fluids Barriers CNS"},{"issue":"5","key":"14583_CR50","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3892\/ol.2024.14681","volume":"28","author":"Q Ge","year":"2024","unstructured":"Ge Q, Zhang ZY, Li SN, Ma JQ, Zhao Z. Liquid biopsy: Comprehensive overview of circulating tumor DNA (Review). Oncol Lett. 2024;28(5):548.","journal-title":"Oncol Lett"},{"issue":"4","key":"14583_CR51","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41416-022-01776-9","volume":"127","author":"M Garc\u00eda-Pardo","year":"2022","unstructured":"Garc\u00eda-Pardo M, Makarem M, Li JJN, Kelly D, Leighl NB. Integrating circulating-free DNA (cfDNA) analysis into clinical practice: opportunities and challenges. Br J Cancer. 2022;127(4):592\u2013602.","journal-title":"Br J Cancer"},{"issue":"5","key":"14583_CR52","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/CEJ.0000000000000790","volume":"32","author":"Y Hao","year":"2023","unstructured":"Hao Y, Li G. Risk and prognostic factors of brain metastasis in lung cancer patients: a Surveillance, Epidemiology, and End Results population-based cohort study. Eur J Cancer Prev. 2023;32(5):498\u2013511.","journal-title":"Eur J Cancer Prev"},{"issue":"16","key":"14583_CR53","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.3390\/cancers13163923","volume":"13","author":"D Di Capua","year":"2021","unstructured":"Di Capua D, Bracken-Clarke D, Ronan K, Baird AM, Finn S. The Liquid Biopsy for Lung Cancer: State of the Art, Limitations and Future Developments. Cancers. 2021;13(16):3923.","journal-title":"Cancers"},{"issue":"11","key":"14583_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.766","volume":"5","author":"L Li","year":"2024","unstructured":"Li L, Sun Y. Circulating tumor DNA methylation detection as biomarker and its application in tumor liquid biopsy: advances and challenges. MedComm. 2024;5(11): e766.","journal-title":"MedComm"},{"issue":"3","key":"14583_CR55","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41416-021-01626-0","volume":"126","author":"V Mishra","year":"2022","unstructured":"Mishra V, Singh A, Chen X, Rosenberg AJ, Pearson AT, Zhavoronkov A, et al. Application of liquid biopsy as multi-functional biomarkers in head and neck cancer. Br J Cancer. 2022;126(3):361\u201370.","journal-title":"Br J Cancer"},{"issue":"3","key":"14583_CR56","doi-asserted-by":"publisher","first-page":"100320","DOI":"10.1016\/j.xhgg.2024.100320","volume":"5","author":"X Wang","year":"2024","unstructured":"Wang X, Hou K, Ricciuti B, Alessi JV, Li X, Pecci F, et al. Additional impact of genetic ancestry over race\/ethnicity to prevalence of KRAS mutations and allele-specific subtypes in non-small cell lung cancer. Hum Genet Genomics Adv. 2024;5(3):100320.","journal-title":"Hum Genet Genomics Adv"},{"issue":"2","key":"14583_CR57","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/JTO.0000000000000420","volume":"10","author":"A Bollig-Fischer","year":"2015","unstructured":"Bollig-Fischer A, Chen W, Gadgeel SM, Wenzlaff AS, Cote ML, Schwartz AG, et al. Racial diversity of actionable mutations in non-small cell lung cancer. J Thorac Oncol. 2015;10(2):250\u20135.","journal-title":"J Thorac Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14583-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14583-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14583-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T08:56:59Z","timestamp":1757321819000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14583-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14583"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14583-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]},"assertion":[{"value":"22 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1246"}}